To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.
- Sponsor
- Royal Cornwall Hospitals Trust
- Study ID
- NCT06849284
- Status
- Recruiting
Conditions
- Thyroid Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
To perform a post-market study of the performance of the Idylla™ ThyroidPrint® Assay using clinical samples in predicting the nature of indeterminate thyroid nodules (ITNs) across multiple centers.
Key Dates
- First listed
- Feb 27, 2025
- Start date
- Dec 16, 2024
- Status verified
- Dec 2024
- Primary completion
- Jun 30, 2025
- Completion
- Jun 30, 2025
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Primary endpoints [ Time Frame: Samples taken at Baseline ]
Central Contacts
- Verity Teague Research Sponsorship Facilitator0044 1872256429
Related Studies
- Studies on Tumors of the ThyroidRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Hereditary Risk Factors for Thyroid CancerRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California